Showing posts with label industry. Show all posts
Showing posts with label industry. Show all posts

Monday, 30 January 2017

AAATE2017 - Call for Papers open until 10.02.17


The Call for Papers for the AAATE2017 Conference is open until 10.02.2017 17.00 CET.
Please click here to see our new AAATE2017 flyer.
We invite you to submit a full or short paper to the Conference on ANY topic relevant to assistive or enabling technology as well as services that make use of such technologies.
Share your new knowledge or call for action in the domains of learning, communication, mobility, self-care, domestic life, relationships, employment and civic life.
Please submit your paper on ANY AT topic or one related to any of our 35 Special Thematic Sessions via the Conference Management Tool.

AAATE contributors:

Please share this with your networks and print the poster for your display boards. 

Thursday, 26 January 2017

First Networking Lunch of 2017 kicks off with a bang!

The CATCH community gathered this week for the first Networking Lunch of 2017.

More than 30 academics, researchers, Professional Services staff, partners and visitors attended the lunch, held in the iconic University building, Firth Court.

We were delighted to be joined by Professor Mike Trenell with his presentation: Digital health and diabetes - hype or hope? Mike is a Professor of Metabolism and Lifestyle Medicine at Newcastle University. His charismatic talk resonated with the network as members of the audience eagerly asked questions on his research and the NIHR Innovation Observatory of which he’s Director.

Simon Butler, CATCH Centre Manager also excitedly shared the upcoming events that shouldn’t be missed in 2017. From Luc de Witte’s Inaugural Lecture and CATCH showcase on 10th - 11th March as part of the Sheffield Festival of Science and Engineering to the AAATE2017 in September, where the Call for Papers is open until 10th February 2017.

The next Networking Lunch will be held on Tuesday 14th March 2017 in conjunction with the ScHARR seminar series. In the Pemberton Lecture Theatre B, Regent Court, the lunch will take place at the earlier time of 12.00 - 14.00. Our guest speaker, Matthew Machin, mHealth Applications Manager in the Centre for Health Informatics at the University of Manchester will speak around “Improving Health in Long-term Conditions with Smartphone Apps and Wearable Devices.”

Please contact Laura Murray if you would like to attend (l.murray@sheffield.ac.uk)


Monday, 16 January 2017

High-tech, high-touch ways to engage patients, members

Payers and providers have been intent on engaging patients and members. And for good reason: It can foster loyalty, build trust and encourage proactive healthy behavior, which all lead to reduced healthcare costs and lower consumption of healthcare services.

"If we're going to make connected health a widespread reality in the lives of consumers and patients, we have to double down on engagement," says Joseph Kvedar, M.D., vice president of connected health at Boston-based Partners HealthCare.

While an NEJM Catalyst survey reveals that 69% of providers are using patient engagement strategies, the figure should be much higher, says Kevin Volpp, M.D., Ph.D., director of the Center for Health Incentives and Behavioral Economics at the University of Pennsylvania’s Perelman School of Medicine.

But even as health information technology programs and platforms advance the cause, there are still some low-tech and high-touch ways to engage patients. The best methods, of course, are a blend of the two. 

Friday, 13 January 2017

2016 a banner year for EHR security breaches

Security breaches of electronic protected health information (ePHI) continue to plague the healthcare industry—and the trend shows no signs of abating.
More than 25 million patient records were reportedly compromised as of October 2016. And then, in November, the cases spiked: There were 57 health data breaches—the most in any one month this year, according to the Protenus Breach Barometer. 
What’s even more concerning is that inside employees were responsible for more than half of November's breaches, a notable increase from past months. 

Thursday, 12 January 2017

Hospital Impact: EHRs, health IT slouch toward 2017

2016 was a busy year for healthcare information technology in general and EHRs in particular. Electronic health records have matured—in part. Sometimes it seems like the industry takes two steps back for every step forward.

Incentive programs have evolved, but interoperability efforts have been rocky. Data analytics are more robust than ever, but on HIPAA's 20th birthday, cyberthreats are on the rise.

Let's take a look at five of the biggest EHR-related issues of the past year, how they unfolded and where we’re headed in the coming year.

1.       The evolution of the EHR incentive programs
2.       Interoperability: Two steps forward, one step back
3.       Cyberthreats on the rise
4.       A stalemate on EHRs and patient safety
5.       The maturation of EHRs—in part

Tuesday, 10 January 2017

FDA lays out postmarket medical device cybersecurity recs in final guidance.

As our world becomes more interconnected, so do our medical devices: we are connecting devices such as insulin pumps and glucose meters to apps, some of which also have cloud connectivity, enabling patients to share their health data with caregivers and loved ones. But this increased interconnectivity comes with vulnerability to cybersecurity threats.

The FDA published its final guidance on the postmarket management of cybersecurity in medical devices last week. The recommendations apply to medical devices that use software, including programmable logic and software that is regulated as a medical device, including mobile medical apps. The document follows the agency’s final guidance on premarket cybersecurity for medical devices issued in 2014.

Wednesday, 7 December 2016

Have you ever thought that research is something that happens but nothing really ever happens as a result of it? And if it does you never really see the results?

The aim of CLAHRC (Collaboration for Leadership in applied Health Research and Care) aims to conduct research that is implemented into healthcare and also involves members of the public. 

CLAHRC is split into themes and there is more than one CLAHRC in the UK.

You can learn about one of the CLAHRCs (Yorkshire and Humber, YH) here: http://clahrc-yh.nihr.ac.uk

You can learn about CLAHRC YH themes here: http://clahrc-yh.nihr.ac.uk/our-themes

Friday, 25 November 2016

Takeda teams up with Koneksa to integrate remote data capture into clinical trials

Takeda is enlisting data integration player Koneksa Health on a scheme to bring new digital health tools to its clinical trials. The partnership will see Takeda using Koneksa’s remote data collection capabilities in trials for multiple pipeline candidates.

The goal of the tie-up is to develop “digital biomarkers” that could support decision-making and eventually contribute to new endpoints that will improve the assessment of patients in their natural environment, according to a statement.

The Japanese pharma will use Koneksa’s platform to integrate biosensors and wearables in a number of early-stage clinical trials, according to the statement. The technology facilitates the collection of patient-generated data that were previously tricky to obtain, such as patients’ continuous vital signs, activity levels and sleep metrics, Takeda said.

Thursday, 24 November 2016

Owlet grabs $15M to advance infant breathing monitor and app

Owlet Baby Care just boosted its total capital raised to $25 million, thanks to a new $15 million in venture financing and an NIH grant. The new infusion will drive the international distribution efforts of its baby monitor that alerts parents via smartphone app if their baby stops breathing.

The Owlet baby monitor comprises a sensor-embedded smart sock, a base station and a smartphone app. The smart sock monitors the infant’s heart rate and oxygen levels using pulse oximetry and communicates this data to the base station via bluetooth. If the child’s heart rate is too low or too high, or if his or her oxygen level falls below a preset threshold, the base station and smartphone app will sound an alert. In 2017, the company expects to launch a feature allowing users more access to these data as well as the ability to share it with pediatricians, according to a statement.

Click here to find out more.


Wednesday, 23 November 2016

FDA clears EOS’ 3D surgical planning software

FDA has given 510(k) clearance to EOS Imaging’s 3D planning software for total knee arthroplasties. The green light continues the run of regulatory successes for EOS, which has now secured the OK to sell its full suite of EOSapps in the U.S.

KneeEOS, the latest app to receive FDA clearance, is the last step in a process that turns front and side-on images from a system sold by EOS into 3D models surgeons can use to plan knee operations. The 3D models generated by EOS’ team and rendered in kneeEOS allow surgeons to choose the size of implant needed for an operation and assess its positioning before starting a procedure. KneeEOS suggests the most appropriate implant and position based on the model.


Tuesday, 22 November 2016

Ava bags $10million for wrist-worn facility tracker

Ava, which focuses on women’s reproductive health, reeled in a $9.7 million Series A funding round, which will drive product development and scale production of its fertility-tracking wristband, as well as propel its expansion into European markets.

The Zurich-based company launched the Ava fertility bracelet in the U.S. in July. It is the first device to track the fertile days of a woman’s menstrual cycle in real time, according to the company.

Worn at night, the device continuously records data on nine physiological measures that reflect a rise in hormones associated with ovulation, according to a statement from the company. These measures include pulse, breathing rate, sleep quality and temperature. In the morning, the data is synced with a mobile app. A recent study showed the tracker was able to identify an average of 5.3 fertile days per cycle with 89 percent accuracy.

Monday, 21 November 2016

Study: 'Vocal biomarkers' can predict likelihood of heart disease

Voice analysis specialist Beyond Verbal and Mayo Clinic unveiled results from a new study demonstrating a strong correlation between some voice characteristics and the presence of coronary artery disease (CAD).

Beyond Verbal, which bills itself as an emotions analytics company, focuses on extracting as much information as possible from the tone of voice of a speaker, said CEO Yuval Mor. Voice analysis may be used to understand emotions and well-being, he said. We can tell with the human ear, for example, if a person is feeling well or not. The new study data confirms that we can also understand a medical condition by using voice feature analysis.

The double-blind study involved 120 patients who had been referred for elective coronary angiography and 120 control patients. Beyond Verbal provided Mayo Clinic with acoustic features, and the latter zeroed in on some characteristics that could “strongly and independently” be associated with CAD, Mor said. In particular, one feature was linked to a 19-fold higher likelihood of CAD, the companies said in a statement.

Friday, 11 November 2016

J&J to create new Texas center to develop ‘breakthrough’ med tech

Johnson & Johnson is pulling out all the stops in its efforts to turn around its medical devices business. After a restructuring early this year, the J&J medical device business actually grew--albeit only by 0.7%--to $6.2 billion last quarter.

The pharma's arm that invests in new technology, Johnson & Johnson Innovation (JJI), is doing its bit to try to help encourage the success of those efforts in the long term. It’s creating the new Center for Device Innovation at the Texas Medical Center (TMC) in Houston, which is intended to enable the entire process of creating “breakthrough” medical devices, the company said.


Thursday, 10 November 2016

Sensimed signs Japanese manufacturer to bring diagnostic contact lens into Asia

Swiss contact lens development company Sensimed is joining forces with SEED, a Japanese manufacturer, to bring its FDA-approved Triggerfish glaucoma lens to that country’s market. The companies are devoting 10 million Swiss francs ($10.1 million) to support Japanese registration and further tests.

Sensimed’s Triggerfish is a soft contact lens with an embedded microsensor that captures eye measurements and intraocular pressure over a 24-hour period and relays the data via Bluetooth to related computer software. The technology gained FDA approval in March.

For further information please click here.

Wednesday, 9 November 2016

Newcastle University testing wearable to restore hand, arm function in stroke survivors

Newcastle University is testing a wearable device in partially paralyzed stroke patients to see if it can restore hand and arm function.
The device, about the size of a mobile phone, strengthens connections between the brain and spinal cord by delivering electrical shocks to the arm and making audible clicks, according to a statement. The treatment is delivered via a pad on the arm and an earpiece. The clicks and electrical stimulation are delivered continuously.
"We think that if they wear this for 4 hours a day we will be able to see a permanent improvement in their extensor muscle connections which will help them gain control on their hand,” said Stuart Baker, a professor of movement neuroscience at Newcastle University, in the statement.

For more detail, please click here.

Monday, 24 October 2016

NIHR Devices for Dignity Healthcare Technology Co-operative


Why is it so important to consider dignity during technology development?
The development of technology to assist or simplify medical diagnoses, treatment and management can provide the opportunity to greatly improve patient experiences and medical outcomes.  However, addressing only the patient’s clinical needs in isolation misses the opportunity to achieve genuinely effective solutions. For patients, their ability to live with dignity can have a big impact on their health and happiness. Truly effective and enduring technologies should therefore be developed with users, and should consider how, where and when they will use the technology; if a user dislikes using a technology, they are less likely to use it. An example of a technology that D4D is developing in partnership with patients and other collaborators is the Sheffield Support Snood collar for people with neck muscle weakness. The collar has been designed to be more wearable and adaptable than other support collars, and is currently undergoing a clinical evaluation.
“Other, more rigid collars were painful – I couldn’t wear them for too long, I can wear this collar for 8 hours straight  – I wear it at work” -Anonymous patient participant comment in clinical study of new collar design
“This collar gives support but also more freedom of movement – I can wear it to drive”- Anonymous patient participant comment in the clinical study of the new collar design
By developing technologies around users’ wider needs rather than just patients’ clinical needs, and by taking into account the needs of everyone involved in a project from early stages, projects can be designed well, and all partners can benefit. 
·       Patients can experience fewer disruptions and exert greater control over their lives, which is likely to lead to greater satisfaction and adherence to their treatment, and better wellbeing.
·       Healthcare professionals are also users of technologies with their patients, so clinical input into device design can help ensure that technology adoption challenges are anticipated early in the development process and can be addressed in the context of existing practices, training and systems.
·       Technology companies can develop solutions that are likely to be better received by the patients and clinicians using them.
The resulting well-designed technologies are more beneficial to patients and users, so may benefit from patient- and clinical ‘pull’, which helps ensure the solution is widely sought, can help drive faster widespread adoption, and helps the company to establish itself more effectively within the health market place.
For this reason D4D works closely with and values the involvement of patients and carers, clinicians, researchers, designers, charities and industry partners when developing technology solutions. By building such partnerships we can ensure that the solutions that we develop maintain or promote people’s dignity - and by extension their wellbeing - at the same time as addressing their clinical needs.


Partners in the development of the Sheffield Support Snood are the Sheffield Institute for Translational Neuroscience (SITRaN) at the University of Sheffield, Sheffield Hallam University, Sheffield Teaching Hospitals NHS FT, Barnsley NHS FT and the Motor Neurone Disease Association (MNDA).